-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Previous studies reported that anti-Müllerian hormone (AMH), a marker of ovarian reserve, was positively associated with breast cancer risk.
Breast cancer
Recently, the Journal of Clinical Endocrinology & Metabolism, an authoritative journal in the field of endocrine and metabolic diseases, published a research article that aims to assess whether risk factors for breast cancer are related to the concentration of AMH
The participants in this cross-sectional study were 3831 healthy premenopausal women (21-57 years old, 35-49 years old accounted for 87%)
After adjusting the age and cohort, the researchers observed that AMH was positively correlated with age at menarche (p<0.
This study is the largest study of the correlation between AMH and breast cancer risk factors in women in the general population (without infertility), and found that most of the correlations are limited to women over 40 years of age who are approaching menopause and whose AMH concentration is declining.
This study is the largest study of the correlation between AMH and breast cancer risk factors in women in the general population (without infertility), and found that most of the correlations are limited to women over 40 years of age who are approaching menopause and whose AMH concentration is declining.
Original source:
Tess V Clendenen.
Breast cancer risk factors and circulating anti- Müllerian hormone concentration in healthy premenopausal women
in this message
